Grant: Discovery Grants Program - Individual
McMaster University
$22,000.00
Differential expression of CRP40 protein and its affects on dopamine-dependent behaviours and dopamine-activity
FY 2010-11
Summary
Catecholamines are neurotransmitters found in both the peripheral and central nervous system (CNS). CNS catecholamines consist of dopamine (DA) and its two hydroxylated products, norepinephrine, and epinephrenine. DA constitutes approximately 80% of catecholamines in the brain and, via its effects on specific receptors, is an important neurochemical mediator in behaviours. Likewise, aberrations in DA activity have been implicated in abnormal behaviour. Importantly, DA's effect in these domains is activity dependent and tightly coupled to extracellular DA levels in the synapse. However, relatively little is known about the molecular mechanisms that regulate levels of DA. The proposed research program seeks to investigate the role of a 40kDa catecholamine regulating protein (CRP40) in governing DA levels and, in turn, DA-dependent behaviour. This line of investigation is interesting given that my lab has shown that CRP40 is a multifunctional protein with catecholamine binding functions. Moreover, CRP40 may act as a scavenging molecule in the presence of excess DA activity. Arguably, these processes each represent potential components in the overall regulation of DA and bolster the suggestion that CRP40 has a fundamental impact on CNS DA levels and, consequently, DA-dependent behaviour. What is missing, however, are studies aimed at experimentally testing the impact of CRP40 manipulations on dopaminergic molecules causing alterations on DA concentrations, and DA-dependent behavior in order to elucidate these putative underlying relationships. The proposed approach in this research program will involve rat brain region specific knock-down of CRP40 mRNA in order to examine how the time-course of CRP40 knockdown and recovery is coupled to changes in several DA-dependent behaviours. Based on the hypothesis that CRP40 regulates DA activity, we predict that dysfunction and recovery of DA-dependent behaviours will follow the time-course of CRP40 protein recovery.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
355500-2009
Name nom
Gabriele, Joseph
Department département
Psychiatry and Behavioural Neurosciences
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2009
Award amount
22000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
12
Committee name en
Psychology: Brain, Behaviour & Cognitive Sciences
Committee name fr
Psychologie: Cerveau, comportement et science cognitive
Area of application code
1210
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Psychology
Area of application fr
Psychologie
Research subject code
6308
Research subject group en
Psychology
Research subject group fr
Psychologie
Research subject en
Behavioural neuroscience
Research subject fr
Neurologie du comportement
Partie
2
Nb partie
5
Application title
Differential expression of CRP40 protein and its affects on dopamine-dependent behaviours and dopamine-activity
Keyword
NSERC
Application summary
Catecholamines are neurotransmitters found in both the peripheral and central nervous system (CNS). CNS catecholamines consist of dopamine (DA) and its two hydroxylated products, norepinephrine, and epinephrenine. DA constitutes approximately 80% of catecholamines in the brain and, via its effects on specific receptors, is an important neurochemical mediator in behaviours. Likewise, aberrations in DA activity have been implicated in abnormal behaviour. Importantly, DA's effect in these domains is activity dependent and tightly coupled to extracellular DA levels in the synapse. However, relatively little is known about the molecular mechanisms that regulate levels of DA. The proposed research program seeks to investigate the role of a 40kDa catecholamine regulating protein (CRP40) in governing DA levels and, in turn, DA-dependent behaviour. This line of investigation is interesting given that my lab has shown that CRP40 is a multifunctional protein with catecholamine binding functions. Moreover, CRP40 may act as a scavenging molecule in the presence of excess DA activity. Arguably, these processes each represent potential components in the overall regulation of DA and bolster the suggestion that CRP40 has a fundamental impact on CNS DA levels and, consequently, DA-dependent behaviour. What is missing, however, are studies aimed at experimentally testing the impact of CRP40 manipulations on dopaminergic molecules causing alterations on DA concentrations, and DA-dependent behavior in order to elucidate these putative underlying relationships. The proposed approach in this research program will involve rat brain region specific knock-down of CRP40 mRNA in order to examine how the time-course of CRP40 knockdown and recovery is coupled to changes in several DA-dependent behaviours. Based on the hypothesis that CRP40 regulates DA activity, we predict that dysfunction and recovery of DA-dependent behaviours will follow the time-course of CRP40 protein recovery.